Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients ...

A fixed duration combination of venetoclax with acalabrutinib, with or without obinutuzumab, was superior to standard ...

There will continue to be an increase in the integration of AI in daily workflows and decision-making as AI increases in ...

Medication errors and adverse drug reactions (ADRs) are major health concerns globally, with ADRs being a leading cause of hospitalisations.

SAN DIEGO -- A fixed-duration oral combination significantly reduced the risk of disease progression or death compared with ...

Dr. Cudkowicz is the Chair of Neurology at MGH, Director of the Sean M. Healey & AMG Center for ALS, and is the Julieanne Dorn Professor of Neurology at Harvard Medical School. A member of the ...

GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the ...

Programme alumni "Being part of Imperial's Pathways to Medicine has given me access to consistent and reliable information that I would otherwise never have, which I am forever grateful for. I have ...

We're focused on streamlining office workflows. By consolidating everything into one platform, managers and staff will be able to access all the information they need in one place, creating greater ...

Pack the following items in your carry-on bag and keep it with you at all times: Medicines you take on a regular basis at home. Take enough medicine for the planned trip plus extra in case your return ...

The process that Government and the Ministry of Health are using when it comes to the Fiji Procurement Office and the Ministry of Finance is that they have to get three quotes for medicine when ...

Lauren Dana Ellman is a New York-based freelance writer and editor who specializes in travel, lifestyle, food, and shopping content. If your friend group prefers the slopes to the sand, look no ...